Ear stimulation device aims to ease chemo side effects in ovarian cancer
NCT ID NCT06817161
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a non-invasive device that gently stimulates a nerve in the ear can improve quality of life by reducing digestive symptoms like nausea and bloating during first-line chemotherapy for ovarian cancer. About 116 women will be randomly assigned to receive either real or sham stimulation alongside their standard treatment. The goal is to see if this simple, drug-free approach can help patients feel better during chemotherapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIGESTIVE SYSTEM DISORDERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU CAEN
NOT_YET_RECRUITINGCaen, France
-
Centre François Baclesse
RECRUITINGCaen, France
-
Centre Henri Becquerel
NOT_YET_RECRUITINGRouen, France
-
Centre Oscar Lambret
NOT_YET_RECRUITINGLille, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Digital therapy aims to tame the fear that haunts cancer survivors
- New PET tracer could spot cancers that standard scans overlook
- Can a mesh shield ovarian cancer patients from painful hernias?
- Two-Drug combo targets Hard-to-Treat ovarian cancer
- Can Mind-Body techniques and drugs ease stress during ovarian cancer surgery?
- Gene therapy safety check: 400 cancer patients monitored for years